Evolocumab Doesn ' t Worsen Glycemia or Up Diabetes Risk: FOURIER Evolocumab Doesn ' t Worsen Glycemia or Up Diabetes Risk: FOURIER

In a large trial with more than 27,000 patients with preexisting CVD and uncontrolled LDL cholesterol, there was no signal of worsening or new-onset diabetes with the PCSK9 inhibitor evolocumab.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news